The year 2022 was another exceptional year from the standpoint of our own brand products, with sales which underscore a total growth of over 30% compared to 2021. The above stems from the quality and reliability of our products, their superior clinical value, and new distributive choices, where DEKA is endorsing interlocutors which are ever more dedicated to their own brand, but who are also rather structured, both from the standpoint of sales and technical support, as well as with regards to training offer and avantgarde post-sale services...